Total 22
| Number | Title | Author | Date | Status | Votes | Views |
| 1 |
[2022] CELLeBRAIN selected for a 1.2 billion KRW national new drug development project by KDDF at candidate material stage
admin
|
2022.09.13
|
Votes 0
|
Views 487
|
admin | 2022.09.13 | 2022 | 0 | 487 |
| 2 |
[2022] CELLeBRAIN selected as one of 20 innovative biotech companies supported by Korea Institute of Toxicology
admin
|
2022.07.27
|
Votes 0
|
Views 321
|
admin | 2022.07.27 | 2022 | 0 | 321 |
| 3 |
[2022] CELLeBRAIN selected for early-stage investment portfolio by Timeworks Investment
admin
|
2022.06.17
|
Votes 0
|
Views 322
|
admin | 2022.06.17 | 2022 | 0 | 322 |
